3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasm Metastasis
2
Colorectal Neoplasms
2
Uveal Melanoma
1
Urologic Neoplasms
1
Thyroid Neoplasms
1
Soft Tissue Neoplasms
1
Sarcoma
1
Recurrence
1
Pharyngeal Neoplasms
1
Pancreatic Neoplasms
1
Neurofibromatosis 2
1
Neoplasms, Mesothelial
1
Neoplasms
1
Myelodysplastic Syndromes
1
Mouth Neoplasms
1
Lymphangioleiomyomatosis
1
Leukemia, Myeloid, Acute
1
Erdheim-Chester Disease
1
Endocrine Gland Neoplasms
1
Disease Progression
1
Colonic Neoplasms
1
Castleman Disease
1
Carcinoma, Transitional Cell
1
Cancer That is Associated With a Chronic Viral Infection
1
Breast Neoplasms
1
Interventions
Nivolumab
6
Ipilimumab
2
Gemcitabine
2
zaleplon
1
temsirolimus
1
relatlimab
1
regorafenib
1
olaparib
1
linrodostat
1
Vorinostat
1
Trastuzumab
1
Standard of Care
1
Sirolimus
1
Rehabilitation
1
Psychotherapy
1
Paclitaxel
1
Oxaliplatin
1
Niacin
1
IFL protocol
1
Health Services Needs and Demand
1
Everolimus
1
Clinical Trials, Phase IV as Topic
1
Cisplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Cancer
×
Valproic Acid
×
1 year
×
Clear all
No trials found.